Introduction C total coronary occlusion remains one of the limitations of percutaneous transluminal coronary angioplasty, and few therapeutic devices are specifically designed to address this problem. Despite advances in device technology, the management of resistant, calcific lesions remains one of the greatest challenges in successful chronic total coronary occlusion intervention. Established...
